Skip to main content
Premium Trial:

Request an Annual Quote

Protein Analytics Firm BioScale Raises $25M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein analytics firm BioScale said today it has raised $25 million in a recent financing round, to be used to commercialize the company's technology.

The round was led by new investor Morningside Venture, as well as existing investors New Science Ventures, WFD Ventures, F2 Ventures, and several individual investors.

BioScale will use the funds to expand manufacturing operations and sales of its ViBE protein analytics systems, the company said in a statement.

ViBE provides highly sensitive reproducible detection and quantitation of analytes in complex biological samples, BioScale said, and allows customers to create and configure their own assays using BioScale's lead technology, called Acoustic Membrane MicroParticle, or AMMP.

AMMP is a label-free non-optical homogeneous assay that allows ultra-sensitive detection in complex matrices at the picogram level.

In a statement, Isaac Cheng of Morningside Venture said that his firm is "excited" about the therapeutic and diagnostic potential of BioScale's protein biomarkers, "and feel BioScale's next-generation proteomics platform is well-positioned to become a leader in the protein measurement space."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.